...
首页> 外文期刊>The pharmaceutical journal >Not enough being done to develop new antibiotics
【24h】

Not enough being done to develop new antibiotics

机译:开发新抗生素还做得不够

获取原文
获取原文并翻译 | 示例
           

摘要

Cases of antibiotic-resistant Escherichia coli are increasing 'while infections from meticillin-resistant Staphylococcus aureus (MRSA) in some parts of the EU may have peaked and even started to decline, according to the conclusions of a new report. Despite the fall in MRSA, the infection is still the most common single multi-drug resistant bacterium in the EU, Iceland and Norway, says the joint report by the European Centre for Disease Prevention and Control and European Medicines Agency (EMEA).
机译:根据一份新报告的结论,在欧盟的某些地区,耐甲氧西林金黄色葡萄球菌(MRSA)的感染病例可能已经达到高峰,甚至开始下降,而抗生素耐药性大肠杆菌的病例正在增加。欧洲疾病预防与控制中心和欧洲药品管理局(EMEA)的联合报告说,尽管MRSA下降,但感染仍然是欧盟,冰岛和挪威最常见的单一多药耐药细菌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号